Alembic Pharmaceuticals Gains After U.S. FDA Issues Form 483 – Shares of the Vadodara-based drug maker rose as much as 4.2 percent, the most in over a month, to Rs 557.85 after the U.S. drug regulator issued Form 483 for its Panelav facility.
Alembic Pharmaceuticals Gains After U.S. FDA Issues Form 483 – Shares of the Vadodara-based drug maker rose as much as 4.2 percent, the most in over a month, to Rs 557.85 after the U.S. drug regulator issued Form 483 for its Panelav facility.